• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator.

作者信息

Jazayeri Mohammad-Ali, Emert Martin P, Bartos JoAnn, Tabbert Ted, Lakkireddy Dhanunjaya R, Jazayeri Mohammad-Reza

机构信息

Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, Kansas.

Bloch Heart Rhythm Center, Mid-America Cardiology, University of Kansas Hospital, Kansas City, Kansas.

出版信息

HeartRhythm Case Rep. 2017 May 25;3(6):306-310. doi: 10.1016/j.hrcr.2017.03.009. eCollection 2017 Jun.

DOI:10.1016/j.hrcr.2017.03.009
PMID:28649503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5469317/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3992/5469317/baf8445904e0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3992/5469317/7f987db3d2cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3992/5469317/baf8445904e0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3992/5469317/7f987db3d2cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3992/5469317/baf8445904e0/gr2.jpg

相似文献

1
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator.在已有经静脉植入式心律转复除颤器的患者中植入皮下植入式心律转复除颤器。
HeartRhythm Case Rep. 2017 May 25;3(6):306-310. doi: 10.1016/j.hrcr.2017.03.009. eCollection 2017 Jun.
2
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证：法国专家立场文件。
Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.
3
The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.皮下植入式心脏复律除颤器：优势、局限性及未来方向。
Expert Rev Cardiovasc Ther. 2015;13(9):989-99. doi: 10.1586/14779072.2015.1071189.
4
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].[青年心脏性猝死。新型皮下植入式心律转复除颤器S-ICD是一种替代解决方案吗？]
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
5
[Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].[心脏复律除颤器的经静脉皮下植入技术]
Herz. 1994 Oct;19(5):259-77.
6
Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians.皮下植入式心律转复除颤器植入术的麻醉：来自美国一组医生临床经验的观点。
Pacing Clin Electrophysiol. 2018 Jul;41(7):807-816. doi: 10.1111/pace.13364. Epub 2018 Jun 8.
7
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.皮下与经静脉植入式心脏除颤器治疗：病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
8
Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.皮下植入式心脏复律除颤器放置的麻醉管理：单中心经验。
J Clin Anesth. 2016 Jun;31:53-9. doi: 10.1016/j.jclinane.2015.11.009. Epub 2016 Mar 22.
9
Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.用于降低心源性猝死的皮下植入式心律转复除颤器的研发。
Ann N Y Acad Sci. 2014 Nov;1329:1-17. doi: 10.1111/nyas.12550. Epub 2014 Oct 10.
10
Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement.皮下植入式心律转复除颤器植入术中减少围手术期并发症的方法。
J Innov Card Rhythm Manag. 2020 May 15;11(5):4100-4105. doi: 10.19102/icrm.2020.110504. eCollection 2020 May.

引用本文的文献

1
Left axillary active can positioning markedly reduces defibrillation threshold of a transvenous defibrillator failing to defibrillate at maximum output.左腋窝主动电极定位可显著降低经静脉除颤器在最大输出时无法除颤的除颤阈值。
HeartRhythm Case Rep. 2018 Oct 23;5(1):36-39. doi: 10.1016/j.hrcr.2018.10.006. eCollection 2019 Jan.

本文引用的文献

1
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2015年心律学会（HRS）/欧洲心律协会（EHRA）/亚太心律学会（APHRS）/拉丁美洲心脏电生理和心脏起搏学会（SOLAECE）关于植入式心脏复律除颤器最佳程控与测试的专家共识声明
Heart Rhythm. 2016 Feb;13(2):e50-86. doi: 10.1016/j.hrthm.2015.11.018. Epub 2015 Dec 1.
2
Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial.植入式心脏复律除颤器患者的术中除颤测试及临床电击疗效：北欧植入式心脏复律除颤器随机临床试验
Eur Heart J. 2015 Oct 1;36(37):2500-7. doi: 10.1093/eurheartj/ehv292. Epub 2015 Jun 25.
3
Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
皮下植入式心律转复除颤器：首家单中心应用于其他心脏植入式电子设备的经验。
Heart Rhythm. 2015 Nov;12(11):2230-8. doi: 10.1016/j.hrthm.2015.06.022. Epub 2015 Jun 12.
4
Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker.皮下植入式心律转复除颤器系统在同侧心外膜起搏器患者中的成功植入。
Indian Pacing Electrophysiol J. 2015 Apr 1;15(1):62-4. doi: 10.1016/s0972-6292(16)30843-9. eCollection 2015 Jan-Feb.
5
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).心脏转复除颤器植入术无需诱发心室颤动：一项单盲、非劣效性、随机对照试验（SIMPLE）。
Lancet. 2015 Feb 28;385(9970):785-91. doi: 10.1016/S0140-6736(14)61903-6. Epub 2015 Feb 23.
6
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.老年患者中一级预防植入式心脏复律除颤器的生存获益：年龄有影响吗？来自5项临床试验的汇总数据分析
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):179-86. doi: 10.1161/CIRCOUTCOMES.114.001306. Epub 2015 Feb 10.
7
Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry.植入式心律转复除颤器时不充分除颤安全裕度的预测因素：来自国家心血管数据注册中心的见解。
J Am Coll Cardiol. 2014 Jul 22;64(3):256-64. doi: 10.1016/j.jacc.2014.01.085.
8
Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.植入式经静脉除颤器是否需要进行除颤测试？：在植入式心脏复律除颤器植入时需要进行除颤测试。
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):337-46. doi: 10.1161/CIRCEP.113.000371.
9
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.全球完全皮下植入式除颤器的经验：来自EFFORTLESS S-ICD注册研究的早期结果。
Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.
10
Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.影响首次植入式心脏复律除颤器植入过程中除颤测试使用的患者、医生及操作因素：来自国家心血管数据注册库（NCDR®）的研究结果
Pacing Clin Electrophysiol. 2013 Dec;36(12):1522-31. doi: 10.1111/pace.12248. Epub 2013 Aug 26.